Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.86 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6249628 | 1.00 | BLM (0.86) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL6254815 | 1.00 | BLM (0.86) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL13343956 | 0.95 | BLM (0.78) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL891189 | 0.95 | BLM (0.78) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL26624410 | 0.93 | BLM (1.00) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL11600716 | 0.93 | BLM (1.00) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL716925 | 0.93 | BLM (1.00) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL5878707 | 0.92 | BLM (0.75) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL8042148 | 0.92 | BLM (0.75) | BLMGABRR1CYP1A2LTA4HACE2 | |
| SCHEMBL5879045 | 0.92 | BLM (0.75) | BLMGABRR1CYP1A2LTA4HACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021186-A1 | Fatty Acid-D-Amino Acid Peptides Conjugates as Anaplerotic Compounds for Use in Treating Propionic Acidemia, Methylmalonic Acidurias, and Energy Metabolic Disorders | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-01-22 | — | — | US | claimed |
| EP-4565325-A2 | FATTY ACID-D-AMINO ACID PEPTIDES CONJUGATES AS ANAPLEROTIC COMPOUNDS FOR USE IN TREATING PROPIONIC ACIDEMIA, METHYLMALONIC ACIDURIAS, AND ENERGY METABOLIC DISORDERS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-06-11 | — | — | EP | claimed |
| CN-119855613-A | Fatty acid-D-amino acid peptide conjugates as anaplerotic compounds for the treatment of hyperuricemia, methylmalonic urine disorder and energy metabolism disorders | 匹兹堡大学高等教育联邦体系 | 2025-04-18 | — | — | CN | claimed |
| WO-2024030367-A2 | FATTY ACID-D-AMINO ACID PEPTIDES CONJUGATES AS ANAPLEROTIC COMPOUNDS FOR USE IN TREATING PROPIONIC ACIDEMIA, METHYLMALONIC ACIDURIAS, AND ENERGY METABOLIC DISORDERS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-02-08 | — | — | WO | claimed |
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-106061459-A | Fragrance compositions | 宝洁公司 | 2016-10-26 | — | — | CN | claimed |
| CN-116659004-B | Air conditioner | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-26 | — | — | CN | disclosed |
| EP-4711434-A1 | REFRIGERANT CYCLE APPARATUS | Daikin Industries, Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20260021186-A1 | Fatty Acid-D-Amino Acid Peptides Conjugates as Anaplerotic Compounds for Use in Treating Propionic Acidemia, Methylmalonic Acidurias, and Energy Metabolic Disorders | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4234293-B1 | REFRIGERATION CYCLE DEVICE FOR VEHICLE | DAIKIN IND LTD (JP) | 2025-12-24 | — | — | EP | disclosed |
| EP-4641061-A1 | OIL-WELL METAL PIPE | NIPPON STEEL CORPORATION (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12441922-B2 | Refrigerant-containing composition, use of same, refrigerator having same, operation method for said refrigerator, and refrigeration cycle device equipped with same | DAIKIN INDUSTRIES, LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| EP-4245830-B1 | LUBRICANT BASE OIL | KAO CORP (JP) | 2025-09-10 | — | — | EP | disclosed |
| EP-0739884-A2 | Liquid crystal compound and liquid crystal composition containing the same | Takasago International Corporation (JP) | 1996-10-30 | — | — | EP | disclosed |
| EP-0596809-A1 | Beta-diketones, process for their preparation and their use as polymer stabilizers | RHONE-POULENC CHIMIE (FR) | 1994-05-11 | — | — | EP | disclosed |
| US-5041592-A | Organic silicon compounds, hydrolyzates thereof, and rubber plasticizers | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1991-08-20 | — | — | US | disclosed |
| US-4514287-A | MIXING WITH ALUMINUM SULFATE | NIPPON OIL CO., LTD. (JP) | 1985-04-30 | — | — | US | disclosed |
| US-4145497-A | Uranium-containing mixed catalysts and their use for the polymerization of olefins | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
| US-4123465-A | SELECTIVE HYDROGENATION CATALYSTS | HOFFMANN-LA ROCHE INC. (US) | 1978-10-31 | — | — | US | disclosed |
| US-4115417-A | ENANTIOSELECTIVITY | HOFFMANN-LA ROCHE INC. (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021186-A1 | Fatty Acid-D-Amino Acid Peptides Conjugates as Anaplerotic Compounds for Use in Treating Propionic Acidemia, Methylmalonic Acidurias, and Energy Metabolic Disorders | HADHB, HADHA, HADH | BLM 4663/4885GABRR1 589/4885CYP1A2 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.